Bourgeon Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$277K | – | 332 |
|
|
2022
Q4 | $277K | Hold |
1,000
| – | – | 0.07% | 84 |
|
|
2022
Q3 | $267K | Hold |
1,000
| – | – | 0.07% | 79 |
|
|
2022
Q2 | $204K | Hold |
1,000
| – | – | 0.05% | 89 |
|
|
2022
Q1 | $211K | Buy |
+1,000
| New | +$211K | 0.05% | 93 |
|
|
2020
Q1 | – | Sell |
-105
| Closed | -$31K | – | 256 |
|
|
2019
Q4 | $31K | Sell |
105
-25
| -19% | -$7.38K | 0.01% | 133 |
|
|
2019
Q3 | $30K | Buy |
+130
| New | +$30K | 0.02% | 130 |
|
|
2019
Q1 | – | Sell |
-14,066
| Closed | -$4.23M | – | 74 |
|
|
2018
Q4 | $4.23M | Sell |
14,066
-25
| -0.2% | -$7.52K | 2.77% | 15 |
|
|
2018
Q3 | $4.98M | Sell |
14,091
-5,125
| -27% | -$1.81M | 2.57% | 19 |
|
|
2018
Q2 | $5.58M | Sell |
19,216
-15
| -0.1% | -$4.35K | 3% | 14 |
|
|
2018
Q1 | $5.27M | Buy |
19,231
+5,615
| +41% | +$1.54M | 2.88% | 16 |
|
|
2017
Q4 | $4.34M | Sell |
13,616
-110
| -0.8% | -$35K | 2.37% | 16 |
|
|
2017
Q3 | $4.3M | Buy |
13,726
+116
| +0.9% | +$36.3K | 2.53% | 15 |
|
|
2017
Q2 | $3.69M | Sell |
13,610
-10
| -0.1% | -$2.71K | 2.31% | 17 |
|
|
2017
Q1 | $3.72M | Sell |
13,620
-125
| -0.9% | -$34.2K | 2.33% | 17 |
|
|
2016
Q4 | $3.9M | Buy |
13,745
+350
| +3% | +$99.3K | 2.45% | 17 |
|
|
2016
Q3 | $4.19M | Sell |
13,395
-2,155
| -14% | -$675K | 2.69% | 16 |
|
|
2016
Q2 | $3.76M | Buy |
15,550
+1,590
| +11% | +$384K | 2.44% | 18 |
|
|
2016
Q1 | $3.63M | Sell |
13,960
-330
| -2% | -$85.9K | 2.43% | 17 |
|
|
2015
Q4 | $4.38M | Buy |
14,290
+6,490
| +83% | +$1.99M | 2.81% | 11 |
|
|
2015
Q3 | $2.28M | Buy |
+7,800
| New | +$2.28M | 1.59% | 24 |
|